Pancreatic Cancer Research

ResearcherColumbia UniversityActive in the last 2 years

Kensuke Suzuki

Matched on ORCID iD 0009-0004-8560-589X; OpenAlex author ID A5005244340. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
33
Papers, trials and grants by year

2017: 2 papers · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 2 papers · 2025: 1 paper

Papers 8

  1. Inhibition of C5a-C5aR1 axis suppresses tumour progression by enhancing antitumour immunity and chemotherapeutic effect in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41416-025-03185-0↗
  2. Preoperative Prediction of Long-Term Survival After Surgery in Patients with Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-024-15648-4↗
  3. [Ⅳ. Recent Topics of Precision Medicine for Patients with Pancreatic Cancer]. Co-author PMID 39571982↗
  4. PTHrP Drives Pancreatic Cancer Growth and Metastasis and Reveals a New Therapeutic Vulnerability. Co-author DOI 10.1158/2159-8290.cd-20-1098↗
  5. PRRX1 isoforms cooperate with FOXM1 to regulate the DNA damage response in pancreatic cancer cells. Co-author DOI 10.1038/s41388-019-0725-6↗
  6. Regulation of Epithelial Plasticity Determines Metastatic Organotropism in Pancreatic Cancer. Co-author DOI 10.1016/j.devcel.2018.05.025↗
  7. Grainyhead-like 2 (GRHL2) regulates epithelial plasticity in pancreatic cancer progression. Co-author DOI 10.1002/cam4.1212↗
  8. Metadherin promotes metastasis by supporting putative cancer stem cell properties and epithelial plasticity in pancreatic cancer. Co-author DOI 10.18632/oncotarget.19802↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shigetsugu Takano · 6 shared papers, 2017–2025 · strength 0.90
  2. Masayuki Ohtsuka · 6 shared papers, 2017–2025 · strength 0.90
  3. Hitoe Nishino · 4 shared papers, 2017–2024 · strength 0.54
  4. Takanori Konishi · 2 shared papers, 2024 · strength 0.40
  5. Jason Robert Pitarresi · 3 shared papers, 2018–2021 · strength 0.27
  6. Ryotaro Eto · 1 shared paper, 2025 · strength 0.27
  7. Benoît Marchand · 2 shared papers, 2019–2021 · strength 0.21
  8. Maximilian Reichert · 2 shared papers, 2018–2019 · strength 0.17
  9. Anil K. Rustgi · 2 shared papers, 2018–2019 · strength 0.17
  10. Basil S. Bakir · 2 shared papers, 2018–2021 · strength 0.16
  11. Shingo Kagawa · 2 shared papers, 2017 · strength 0.14
  12. Masaru Miyazaki · 2 shared papers, 2017 · strength 0.14
  13. Hideyuki Yoshitomi · 2 shared papers, 2017 · strength 0.14
  14. Katsunori Furukawa · 2 shared papers, 2017 · strength 0.14
  15. Robert J. Norgard · 1 shared paper, 2021 · strength 0.10
  16. Yoji Miyahara · 1 shared paper, 2021 · strength 0.10
  17. Jinyang Li · 1 shared paper, 2021 · strength 0.10
  18. Jun Zhao · 1 shared paper, 2021 · strength 0.10
  19. Ben Z. Stanger · 1 shared paper, 2021 · strength 0.10
  20. Anil K. Rustgi · 1 shared paper, 2021 · strength 0.10
  21. Anirban Maitra · 1 shared paper, 2021 · strength 0.10
  22. Faiyaz Notta · 1 shared paper, 2021 · strength 0.10
  23. Reiri Shimazaki · 1 shared paper, 2017 · strength 0.07
  24. Karin Feldmann · 1 shared paper, 2018 · strength 0.06
  25. Wilko Weichert · 1 shared paper, 2018 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.